Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-14-028069

10% owner bought 944,290 shares at $7.00 ($6,610,030)

  • 10% owner acquired 2,070,727 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

VENROCK ASSOCIATES V LP · 10% owner

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2014-04-15 Conversion : show line 1 in the form +355,307 355,307 I
2014-04-15 Conversion : show line 2 in the form +128,827 484,134 I
2014-04-15 Conversion : show line 3 in the form +292,675 776,809 I
2014-04-15 Conversion : show line 4 in the form +409,728 1,186,537 I
2014-04-15 Conversion : show line 5 in the form +379,160 1,565,697 I
2014-04-15 Conversion : show line 6 in the form +247,501 1,813,198 I
2014-04-15 Conversion : show line 7 in the form +257,529 2,070,727 I
2014-04-15 Purchase : show line 8 in the form +944,290 $7.00 $6,610,030 3,015,017 I
Open-market purchases · 944,290 sh · avg $7.00 · $6,610,030

Table II: Derivative

9 lines
Date Transaction Shares Owned after D/I
2014-04-15 Conversion : show line 9 in the form Series A Convertible Preferred Stock −5,154,653 0 I
2014-04-15 Conversion : show line 10 in the form Series B Convertible Preferred Stock −1,868,955 0 I
2014-04-15 Conversion : show line 11 in the form Series B-1 Convertible Preferred Stock −4,245,941 0 I
2014-04-15 Conversion : show line 12 in the form Series C Convertible Preferred Stock −5,944,145 0 I
2014-04-15 Conversion : show line 13 in the form Series D Convertible Preferred Stock −5,500,704 0 I
2014-04-15 Other disposition : show line 14 in the form Warrant to purchase Series C Convertible Preferred Stock −275,977 0 I
2014-04-15 Other acquisition : show line 15 in the form Warrant to purchase Common Stock +19,022 19,022 I
2014-04-15 Conversion : show line 16 in the form 7% Convertible Promissory Notes −0 0 I
2014-04-15 Conversion : show line 17 in the form 7% Convertible Promissory Notes −0 0 I
Loading xslF345X03/doc4.xml…